The Technical Advisory Group (TAG) of the World Health Organization (WHO) has sought additional information from Bharat Biotech to consider inclusion of the vaccine in the Approved List for Emergency Use (EUL).
The advisory group is assessing the risks and benefits of the vaccine. The advisory group will now meet on November 3 to consider the issue of covaccine.
Hyderabad-based Bharat Biotech applied for the EUL to the WHO on 19 April. The covaccine has been found to be 77.8 percent effective against corona and 65.2 percent effective against the delta variant.
In June, the company had said it had completed the final assessment of Phase III results. A TAG meeting was held on Tuesday to consider the inclusion of the vaccine in the EUL.
Those traveling abroad are still facing restrictions despite taking this ticket. Restrictions on travel are still in force on the person taking this vaccine as the WHO has not approved this vaccine.
Because of this.
Such hinge holders are considered to be unvaccinated in the general category.
Despite the stay, RT PCR test report will have to be kept like a normal citizen.
There are problems with permits on international flights, or being quarantined upon landing.
A large number of Indians working abroad are feeling trapped after the indigenous ticks are installed.
